Conference Coverage

EndoPredict results reflected tumor response to neoadjuvant therapy

Publish date: January 2, 2018

 

REPORTING FROM SABCS 2017

SOURCE: Dubsky P et al. SABCS 2017 Abstract GS6-04.

Pages

Recommended Reading

High rate of arm morbidity in young breast cancer survivors
Breast Cancer ICYMI
Postmenopausal women who shed pounds see lower breast cancer risk
Breast Cancer ICYMI
Path CR signals good outcomes in treated high-risk breast cancers
Breast Cancer ICYMI
DCIS risk signature is validated in SweDCIS population
Breast Cancer ICYMI
ERBB2 expression predicts pCR in HER2+ breast cancer
Breast Cancer ICYMI
Axillary node dissection can be avoided with limited SLN involvement
Breast Cancer ICYMI
Lapatinib plus trastuzumab improves outcomes in HER2+ breast cancer
Breast Cancer ICYMI
Pertuzumab approved for HER2-positive breast cancer
Breast Cancer ICYMI
Enzalutamide plus exemestane improves PFS in HR+ breast cancer subset
Breast Cancer ICYMI
Wider margins may reduce recurrence risk in early breast cancer
Breast Cancer ICYMI